SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
46.74 EUR
-0.23 (-0.49%)
Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 68 industry peers in the Health Care Equipment & Supplies industry. SHL has a medium profitability rating, but doesn't score so well on its financial health evaluation. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
In the past year SHL had a positive cash flow from operations.
SHL had positive earnings in each of the past 5 years.
Each year in the past 5 years SHL had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 4.83%, SHL is doing good in the industry, outperforming 64.71% of the companies in the same industry.
SHL has a Return On Equity of 11.88%. This is in the better half of the industry: SHL outperforms 69.12% of its industry peers.
SHL has a better Return On Invested Capital (7.66%) than 60.29% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.73%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.66%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.66% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
SHL has a better Profit Margin (9.17%) than 66.18% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
The Operating Margin of SHL (13.53%) is better than 61.76% of its industry peers.
SHL's Operating Margin has been stable in the last couple of years.
SHL has a Gross Margin of 38.63%. This is in the lower half of the industry: SHL underperforms 77.94% of its industry peers.
In the last couple of years the Gross Margin of SHL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
SHL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SHL has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, SHL has more shares outstanding
SHL has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.11 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.11, SHL is in line with its industry, outperforming 47.06% of the companies in the same industry.
The Debt to FCF ratio of SHL is 5.45, which is a neutral value as it means it would take SHL, 5.45 years of fcf income to pay off all of its debts.
SHL has a Debt to FCF ratio of 5.45. This is comparable to the rest of the industry: SHL outperforms 52.94% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.63, SHL is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2.11 |
ROIC/WACC1.25
WACC6.14%
2.3 Liquidity
A Current Ratio of 1.11 indicates that SHL should not have too much problems paying its short term obligations.
SHL has a Current ratio of 1.11. This is in the lower half of the industry: SHL underperforms 72.06% of its industry peers.
SHL has a Quick Ratio of 1.11. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.79, SHL is doing worse than 72.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
SHL shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.17%.
SHL shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.29% yearly.
SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.53%.
Measured over the past years, SHL shows a quite strong growth in Revenue. The Revenue has been growing by 10.08% on average per year.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
Based on estimates for the next years, SHL will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.85% on average per year.
The Revenue is expected to grow by 5.74% on average over the next years.
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y9.85%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.74%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.56, SHL is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 82.35% of the companies listed in the same industry.
SHL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 19.62 indicates a rather expensive valuation of SHL.
63.24% of the companies in the same industry are more expensive than SHL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.04, SHL is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.56 | ||
| Fwd PE | 19.62 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than 61.76% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SHL is valued cheaper than 82.35% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.43 | ||
| EV/EBITDA | 14.56 |
4.3 Compensation for Growth
SHL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.73
EPS Next 2Y6.49%
EPS Next 3Y8.77%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.15%, SHL has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.13, SHL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.92, SHL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
FRA:SHL (1/13/2026, 5:36:15 PM)
46.74
-0.23 (-0.49%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.21%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap52.72B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts78.57
Price Target56.61 (21.12%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.15% |
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-0.51%
PT rev (3m)-8.52%
EPS NQ rev (1m)-2.15%
EPS NQ rev (3m)-10.29%
EPS NY rev (1m)-2.06%
EPS NY rev (3m)-8.85%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)1.58%
Revenue NY rev (1m)-0.24%
Revenue NY rev (3m)-1.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.56 | ||
| Fwd PE | 19.62 | ||
| P/S | 2.26 | ||
| P/FCF | 19.43 | ||
| P/OCF | 14.93 | ||
| P/B | 2.92 | ||
| P/tB | N/A | ||
| EV/EBITDA | 14.56 |
EPS(TTM)2.39
EY5.11%
EPS(NY)2.38
Fwd EY5.1%
FCF(TTM)2.41
FCFY5.15%
OCF(TTM)3.13
OCFY6.7%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)N/A
PEG (5Y)1.73
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.66% | ||
| ROICexc | 8.32% | ||
| ROICexgc | 43.55% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.21% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.11 |
F-Score8
WACC6.14%
ROIC/WACC1.25
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y-0.32%
EPS Next 2Y6.49%
EPS Next 3Y8.77%
EPS Next 5Y9.85%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year2.83%
Revenue Next 2Y4.53%
Revenue Next 3Y5.13%
Revenue Next 5Y5.74%
EBIT growth 1Y12.56%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year34.58%
EBIT Next 3Y17.72%
EBIT Next 5Y14.4%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
Can you provide the valuation status for SIEMENS HEALTHINEERS AG?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 19.56 and the Price/Book (PB) ratio is 2.92.
How financially healthy is SIEMENS HEALTHINEERS AG?
The financial health rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 3 / 10.